{"id":"NCT00599872","sponsor":"Greer Laboratories","briefTitle":"Efficacy Study of Sublingual Immunotherapy to Treat Ragweed Allergies","officialTitle":"Parallel, Randomized, Double-Blind, Placebo-Controlled Trial in Adults for the Sublingual-Oral Immunotherapy (SLIT) of Allergic Rhinoconjunctivitis With or Without Asthma Caused By Ragweed Pollen","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-03","primaryCompletion":"2008-11","completion":"2008-12","firstPosted":"2008-01-24","resultsPosted":"2015-01-14","lastUpdate":"2015-01-14"},"enrollment":430,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Allergic Rhinitis"],"interventions":[{"type":"BIOLOGICAL","name":"Standardized Ragweed Allergenic Extract","otherNames":[]},{"type":"BIOLOGICAL","name":"Placebo","otherNames":[]}],"arms":[{"label":"Ragweed Allergenic Extract","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine an effective dose range for the administration of ragweed allergenic extract via the sublingual route of administration","primaryOutcome":{"measure":"Scores on a Scale (Average of Daily Rhinoconjunctivitis Symptom Score (RSS) Recorded During the Ragweed Season","timeFrame":"Ragweed pollen season, 08/01/08 to 10/30/08, approximately 3 months","effectByArm":[{"arm":"Active","deltaMin":6.2,"sd":6.2},{"arm":"Placebo","deltaMin":6.5,"sd":5.61}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.05"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":2},"locations":{"siteCount":30,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":216},"commonTop":[]}}